Niagen Bioscience, Inc. (NAGE)
2.15
-0.13
(-5.70%)
USD |
NASDAQ |
Nov 10, 16:00
2.14
-0.01
(-0.47%)
After-Hours: 20:00
Niagen Bioscience Total Liabilities (Quarterly) : 25.62M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 25.62M |
| June 30, 2026 | 24.06M |
| March 31, 2026 | 32.00M |
| December 31, 2025 | 29.87M |
| September 30, 2025 | 27.46M |
| June 30, 2025 | 27.33M |
| March 31, 2025 | 25.99M |
| December 31, 2024 | 22.18M |
| September 30, 2024 | 22.15M |
| June 30, 2024 | 23.32M |
| March 31, 2024 | 25.13M |
| December 31, 2023 | 26.51M |
| September 30, 2023 | 26.18M |
| June 30, 2023 | 26.02M |
| March 31, 2023 | 25.75M |
| December 31, 2022 | 25.38M |
| September 30, 2022 | 24.64M |
| June 30, 2022 | 25.84M |
| March 31, 2022 | 27.05M |
| December 31, 2021 | 26.11M |
| September 30, 2021 | 25.00M |
| June 30, 2021 | 23.70M |
| March 31, 2021 | 25.16M |
| December 31, 2020 | 21.93M |
| September 30, 2020 | 17.93M |
| Date | Value |
|---|---|
| June 30, 2020 | 20.41M |
| March 31, 2020 | 19.06M |
| December 31, 2019 | 19.80M |
| September 30, 2019 | 16.00M |
| June 30, 2019 | 29.40M |
| March 31, 2019 | 20.95M |
| December 31, 2018 | 15.05M |
| September 30, 2018 | 13.62M |
| June 30, 2018 | 11.67M |
| March 31, 2018 | 10.78M |
| December 31, 2017 | 8.890M |
| September 30, 2017 | 8.064M |
| June 30, 2017 | 7.201M |
| March 31, 2017 | 11.68M |
| December 31, 2016 | 9.778M |
| September 30, 2016 | 6.906M |
| June 30, 2016 | 5.332M |
| March 31, 2016 | 10.11M |
| December 31, 2015 | 13.47M |
| September 30, 2015 | 10.71M |
| June 30, 2015 | 10.33M |
| March 31, 2015 | 7.296M |
| December 31, 2014 | 7.610M |
| September 30, 2014 | 4.196M |
| June 30, 2014 | 4.560M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Nature's Sunshine Products, Inc. | 96.55M |
| Cyanotech Corp. | 13.88M |
| Mannatech, Inc. | 31.54M |
| Natural Alternatives International, Inc. | 91.06M |
| USANA Health Sciences, Inc. | 138.38M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 108.69M |
| Shareholders Equity (Quarterly) | 83.07M |
| Debt to Equity Ratio | 0.025 |
| Current Ratio | 5.927 |
| Net Debt Paydown Yield | 0.11% |